2026 Comprehensive Clinical Practice Exam
– Batch 1 (Q1–20) Questions with
Answers & Detailed Rationales
Question 1: A 68-year-old patient with type 2 diabetes mellitus is prescribed a dual GIP/GLP-1
receptor agonist. Which laboratory value should the nurse monitor most closely to assess therapeutic
efficacy and safety per 2026 endocrine guidelines?
A. Fasting blood glucose → Rationale: Incorrect. While fasting glucose reflects short-term control,
HbA1c is the gold standard for monitoring long-term glycemic control and medication efficacy in type
2 diabetes.
B. Hemoglobin A1c → Rationale: Correct. HbA1c reflects average blood glucose over 2–3 months and
is the primary marker for evaluating the effectiveness of GIP/GLP-1 agonists and adjusting therapy per
2026 ADA standards.
C. Serum creatinine → Rationale: Incorrect. Though renal function should be periodically checked,
especially with some glucose-lowering agents, it is not the primary marker for efficacy of this drug
class.
D. Thyroid-stimulating hormone (TSH) → Rationale: Incorrect. TSH is unrelated to glucose metabolism
or GIP/GLP-1 agonist therapy; it is monitored only if thyroid dysfunction is suspected or with specific
medications like amiodarone or lithium.
Answer: B
Question 2: A patient presents with acute chest pain, diaphoresis, and ST-segment elevation in leads
II, III, and aVF. Which intervention should be prioritized within the first 10 minutes of arrival?
A. Administer sublingual nitroglycerin → Rationale: Incorrect. Nitroglycerin may be used for symptom
relief but is not the first priority; it is also contraindicated in right ventricular infarction, which is
common in inferior MI.
B. Obtain a 12-lead ECG → Rationale: Correct. Immediate ECG acquisition within 10 minutes is the
standard of care per 2026 AHA/ACC STEMI guidelines to confirm diagnosis and activate the cath lab
promptly.
C. Start intravenous heparin → Rationale: Incorrect. Anticoagulation is indicated but should follow
ECG confirmation and concurrent with antiplatelet therapy; it is not the initial priority.
D. Administer high-flow oxygen → Rationale: Incorrect. Supplemental oxygen is no longer routinely
recommended unless SpO2 <90% per 2026 guidelines, as it may cause vasoconstriction and worsen
ischemia.
Answer: B
,Question 3: A postoperative patient on day 2 develops sudden dyspnea, tachycardia, and a pleuritic
chest pain. D-dimer is elevated. Which diagnostic test is the gold standard to confirm the suspected
condition?
A. Chest X-ray → Rationale: Incorrect. CXR may show nonspecific findings like atelectasis or effusion
but cannot confirm pulmonary embolism.
B. Ventilation-perfusion (V/Q) scan → Rationale: Incorrect. V/Q scan is an alternative when CT is
contraindicated (e.g., severe contrast allergy, renal failure) but is less specific and no longer the first-
line gold standard.
C. CT pulmonary angiography (CTPA) → Rationale: Correct. CTPA is the gold standard for diagnosing
pulmonary embolism in 2026 clinical practice due to high sensitivity, rapid acquisition, and ability to
visualize alternative diagnoses.
D. Lower extremity venous ultrasound → Rationale: Incorrect. Useful for diagnosing DVT, which may
be the source, but does not confirm pulmonary embolism directly.
Answer: C
Question 4: A nurse is educating a patient with newly diagnosed hypertension about lifestyle
modifications. Which recommendation aligns with 2026 cardiovascular prevention guidelines?
A. Limit sodium to <2,300 mg/day → Rationale: Incorrect. Current 2026 guidelines recommend a
stricter limit of <1,500 mg/day for optimal BP control in hypertensive adults.
B. Engage in 150 minutes of moderate aerobic activity weekly → Rationale: Correct. This aligns with
2026 ACC/AHA and WHO recommendations for BP reduction, cardiovascular risk reduction, and
overall metabolic health.
C. Increase dietary saturated fat to improve lipid profiles → Rationale: Incorrect. Saturated fat should
be limited (<10% of calories) and replaced with unsaturated fats to improve lipid profiles and reduce
cardiovascular risk.
D. Restrict fluid intake to 1 L/day → Rationale: Incorrect. Fluid restriction is only indicated in specific
conditions (e.g., advanced heart failure, SIADH); it is not a standard hypertension intervention.
Answer: B
Question 5: A patient receiving vancomycin develops flushing, pruritus, and hypotension during
infusion. The nurse recognizes this as:
A. Anaphylaxis → Rationale: Incorrect. Anaphylaxis involves bronchospasm, angioedema, and severe
hypotension; it is IgE-mediated and not specifically linked to vancomycin infusion rate.
B. Red man syndrome → Rationale: Correct. This is a histamine-mediated reaction caused by rapid
vancomycin infusion, characterized by flushing, pruritus, and sometimes hypotension; it is prevented
by slowing the infusion rate.
C. Serum sickness → Rationale: Incorrect. Serum sickness presents days to weeks after exposure with
fever, rash, arthralgia, and lymphadenopathy, not immediately during infusion.
D. Stevens-Johnson syndrome → Rationale: Incorrect. SJS is a severe mucocutaneous reaction with
blistering and epidermal detachment, typically developing days after drug initiation, not acutely
during infusion.
Answer: B
Question 6: A 45-year-old patient with a history of chronic kidney disease stage 4 is prescribed
sevelamer. What is the primary therapeutic goal of this medication?
A. Lower serum potassium → Rationale: Incorrect. Sevelamer does not affect potassium; patiromer or
, sodium zirconium cyclosilicate are used for hyperkalemia.
B. Bind dietary phosphate in the GI tract → Rationale: Correct. Sevelamer is a phosphate binder used
in CKD to reduce intestinal phosphate absorption, preventing hyperphosphatemia and secondary
complications like renal osteodystrophy per 2026 KDIGO guidelines.
C. Increase erythropoietin production → Rationale: Incorrect. Erythropoiesis-stimulating agents (e.g.,
epoetin alfa) are used for CKD-related anemia, not sevelamer.
D. Reduce proteinuria → Rationale: Incorrect. ACE inhibitors or ARBs are first-line for proteinuria
reduction in CKD; sevelamer has no direct antiproteinuric effect.
Answer: B
Question 7: A nurse observes a patient with a Glasgow Coma Scale (GCS) score of 7. Which
intervention is the highest priority?
A. Administer IV mannitol → Rationale: Incorrect. Mannitol may be used for elevated ICP, but airway
protection takes precedence in any patient with GCS ≤8.
B. Prepare for endotracheal intubation → Rationale: Correct. GCS ≤8 indicates inability to protect the
airway; securing the airway via intubation is the immediate priority per 2026 ATLS and neurocritical
care standards.
C. Obtain a non-contrast head CT → Rationale: Incorrect. CT is essential for diagnosing intracranial
pathology but must follow airway stabilization and hemodynamic support.
D. Elevate the head of the bed to 30 degrees → Rationale: Incorrect. This helps reduce ICP but is
secondary to securing a patent airway in a comatose patient.
Answer: B
Question 8: A patient with Clostridioides difficile infection is prescribed oral vancomycin. Why is
intravenous vancomycin ineffective for this condition?
A. IV vancomycin does not penetrate the blood-brain barrier → Rationale: Incorrect. While true for
CNS infections, this does not explain ineffectiveness in C. diff colitis.
B. IV vancomycin is not secreted into the intestinal lumen → Rationale: Correct. Oral vancomycin
remains in the GI tract to act locally on C. diff; IV vancomycin achieves poor colonic concentrations
and is ineffective for enteric infections per 2026 IDSA guidelines.
C. IV vancomycin is inactivated by gastric acid → Rationale: Incorrect. Vancomycin is not acid-labile;
this describes drugs like penicillin G or certain macrolides.
D. IV vancomycin causes severe nephrotoxicity → Rationale: Incorrect. Nephrotoxicity is a risk with IV
vancomycin but does not explain its lack of efficacy against C. diff.
Answer: B
Question 9: A postpartum patient develops a headache, visual disturbances, and BP of 158/102 mmHg
at 36 hours after delivery. Which condition is the nurse most likely suspecting?
A. Post-dural puncture headache → Rationale: Incorrect. Typically presents with positional headache
after neuraxial anesthesia; does not cause hypertension or visual changes.
B. Postpartum preeclampsia → Rationale: Correct. Can occur up to 6 weeks postpartum; characterized
by new-onset hypertension, headache, visual changes, and sometimes proteinuria or end-organ
dysfunction per 2026 ACOG guidelines.
C. Gestational diabetes exacerbation → Rationale: Incorrect. Presents with hyperglycemia symptoms
(polyuria, polydipsia, fatigue), not acute hypertension or visual disturbances.
D. Thyroid storm → Rationale: Incorrect. Presents with tachycardia, fever, agitation, and altered
– Batch 1 (Q1–20) Questions with
Answers & Detailed Rationales
Question 1: A 68-year-old patient with type 2 diabetes mellitus is prescribed a dual GIP/GLP-1
receptor agonist. Which laboratory value should the nurse monitor most closely to assess therapeutic
efficacy and safety per 2026 endocrine guidelines?
A. Fasting blood glucose → Rationale: Incorrect. While fasting glucose reflects short-term control,
HbA1c is the gold standard for monitoring long-term glycemic control and medication efficacy in type
2 diabetes.
B. Hemoglobin A1c → Rationale: Correct. HbA1c reflects average blood glucose over 2–3 months and
is the primary marker for evaluating the effectiveness of GIP/GLP-1 agonists and adjusting therapy per
2026 ADA standards.
C. Serum creatinine → Rationale: Incorrect. Though renal function should be periodically checked,
especially with some glucose-lowering agents, it is not the primary marker for efficacy of this drug
class.
D. Thyroid-stimulating hormone (TSH) → Rationale: Incorrect. TSH is unrelated to glucose metabolism
or GIP/GLP-1 agonist therapy; it is monitored only if thyroid dysfunction is suspected or with specific
medications like amiodarone or lithium.
Answer: B
Question 2: A patient presents with acute chest pain, diaphoresis, and ST-segment elevation in leads
II, III, and aVF. Which intervention should be prioritized within the first 10 minutes of arrival?
A. Administer sublingual nitroglycerin → Rationale: Incorrect. Nitroglycerin may be used for symptom
relief but is not the first priority; it is also contraindicated in right ventricular infarction, which is
common in inferior MI.
B. Obtain a 12-lead ECG → Rationale: Correct. Immediate ECG acquisition within 10 minutes is the
standard of care per 2026 AHA/ACC STEMI guidelines to confirm diagnosis and activate the cath lab
promptly.
C. Start intravenous heparin → Rationale: Incorrect. Anticoagulation is indicated but should follow
ECG confirmation and concurrent with antiplatelet therapy; it is not the initial priority.
D. Administer high-flow oxygen → Rationale: Incorrect. Supplemental oxygen is no longer routinely
recommended unless SpO2 <90% per 2026 guidelines, as it may cause vasoconstriction and worsen
ischemia.
Answer: B
,Question 3: A postoperative patient on day 2 develops sudden dyspnea, tachycardia, and a pleuritic
chest pain. D-dimer is elevated. Which diagnostic test is the gold standard to confirm the suspected
condition?
A. Chest X-ray → Rationale: Incorrect. CXR may show nonspecific findings like atelectasis or effusion
but cannot confirm pulmonary embolism.
B. Ventilation-perfusion (V/Q) scan → Rationale: Incorrect. V/Q scan is an alternative when CT is
contraindicated (e.g., severe contrast allergy, renal failure) but is less specific and no longer the first-
line gold standard.
C. CT pulmonary angiography (CTPA) → Rationale: Correct. CTPA is the gold standard for diagnosing
pulmonary embolism in 2026 clinical practice due to high sensitivity, rapid acquisition, and ability to
visualize alternative diagnoses.
D. Lower extremity venous ultrasound → Rationale: Incorrect. Useful for diagnosing DVT, which may
be the source, but does not confirm pulmonary embolism directly.
Answer: C
Question 4: A nurse is educating a patient with newly diagnosed hypertension about lifestyle
modifications. Which recommendation aligns with 2026 cardiovascular prevention guidelines?
A. Limit sodium to <2,300 mg/day → Rationale: Incorrect. Current 2026 guidelines recommend a
stricter limit of <1,500 mg/day for optimal BP control in hypertensive adults.
B. Engage in 150 minutes of moderate aerobic activity weekly → Rationale: Correct. This aligns with
2026 ACC/AHA and WHO recommendations for BP reduction, cardiovascular risk reduction, and
overall metabolic health.
C. Increase dietary saturated fat to improve lipid profiles → Rationale: Incorrect. Saturated fat should
be limited (<10% of calories) and replaced with unsaturated fats to improve lipid profiles and reduce
cardiovascular risk.
D. Restrict fluid intake to 1 L/day → Rationale: Incorrect. Fluid restriction is only indicated in specific
conditions (e.g., advanced heart failure, SIADH); it is not a standard hypertension intervention.
Answer: B
Question 5: A patient receiving vancomycin develops flushing, pruritus, and hypotension during
infusion. The nurse recognizes this as:
A. Anaphylaxis → Rationale: Incorrect. Anaphylaxis involves bronchospasm, angioedema, and severe
hypotension; it is IgE-mediated and not specifically linked to vancomycin infusion rate.
B. Red man syndrome → Rationale: Correct. This is a histamine-mediated reaction caused by rapid
vancomycin infusion, characterized by flushing, pruritus, and sometimes hypotension; it is prevented
by slowing the infusion rate.
C. Serum sickness → Rationale: Incorrect. Serum sickness presents days to weeks after exposure with
fever, rash, arthralgia, and lymphadenopathy, not immediately during infusion.
D. Stevens-Johnson syndrome → Rationale: Incorrect. SJS is a severe mucocutaneous reaction with
blistering and epidermal detachment, typically developing days after drug initiation, not acutely
during infusion.
Answer: B
Question 6: A 45-year-old patient with a history of chronic kidney disease stage 4 is prescribed
sevelamer. What is the primary therapeutic goal of this medication?
A. Lower serum potassium → Rationale: Incorrect. Sevelamer does not affect potassium; patiromer or
, sodium zirconium cyclosilicate are used for hyperkalemia.
B. Bind dietary phosphate in the GI tract → Rationale: Correct. Sevelamer is a phosphate binder used
in CKD to reduce intestinal phosphate absorption, preventing hyperphosphatemia and secondary
complications like renal osteodystrophy per 2026 KDIGO guidelines.
C. Increase erythropoietin production → Rationale: Incorrect. Erythropoiesis-stimulating agents (e.g.,
epoetin alfa) are used for CKD-related anemia, not sevelamer.
D. Reduce proteinuria → Rationale: Incorrect. ACE inhibitors or ARBs are first-line for proteinuria
reduction in CKD; sevelamer has no direct antiproteinuric effect.
Answer: B
Question 7: A nurse observes a patient with a Glasgow Coma Scale (GCS) score of 7. Which
intervention is the highest priority?
A. Administer IV mannitol → Rationale: Incorrect. Mannitol may be used for elevated ICP, but airway
protection takes precedence in any patient with GCS ≤8.
B. Prepare for endotracheal intubation → Rationale: Correct. GCS ≤8 indicates inability to protect the
airway; securing the airway via intubation is the immediate priority per 2026 ATLS and neurocritical
care standards.
C. Obtain a non-contrast head CT → Rationale: Incorrect. CT is essential for diagnosing intracranial
pathology but must follow airway stabilization and hemodynamic support.
D. Elevate the head of the bed to 30 degrees → Rationale: Incorrect. This helps reduce ICP but is
secondary to securing a patent airway in a comatose patient.
Answer: B
Question 8: A patient with Clostridioides difficile infection is prescribed oral vancomycin. Why is
intravenous vancomycin ineffective for this condition?
A. IV vancomycin does not penetrate the blood-brain barrier → Rationale: Incorrect. While true for
CNS infections, this does not explain ineffectiveness in C. diff colitis.
B. IV vancomycin is not secreted into the intestinal lumen → Rationale: Correct. Oral vancomycin
remains in the GI tract to act locally on C. diff; IV vancomycin achieves poor colonic concentrations
and is ineffective for enteric infections per 2026 IDSA guidelines.
C. IV vancomycin is inactivated by gastric acid → Rationale: Incorrect. Vancomycin is not acid-labile;
this describes drugs like penicillin G or certain macrolides.
D. IV vancomycin causes severe nephrotoxicity → Rationale: Incorrect. Nephrotoxicity is a risk with IV
vancomycin but does not explain its lack of efficacy against C. diff.
Answer: B
Question 9: A postpartum patient develops a headache, visual disturbances, and BP of 158/102 mmHg
at 36 hours after delivery. Which condition is the nurse most likely suspecting?
A. Post-dural puncture headache → Rationale: Incorrect. Typically presents with positional headache
after neuraxial anesthesia; does not cause hypertension or visual changes.
B. Postpartum preeclampsia → Rationale: Correct. Can occur up to 6 weeks postpartum; characterized
by new-onset hypertension, headache, visual changes, and sometimes proteinuria or end-organ
dysfunction per 2026 ACOG guidelines.
C. Gestational diabetes exacerbation → Rationale: Incorrect. Presents with hyperglycemia symptoms
(polyuria, polydipsia, fatigue), not acute hypertension or visual disturbances.
D. Thyroid storm → Rationale: Incorrect. Presents with tachycardia, fever, agitation, and altered
